576 related articles for article (PubMed ID: 35155214)
1. Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.
Li T; Sun L; Li Q; Luo X; Luo M; Xie H; Wang P
Front Oncol; 2021; 11():825429. PubMed ID: 35155214
[TBL] [Abstract][Full Text] [Related]
2. Magnetic Resonance Imaging Radiomics-Based Machine Learning Prediction of Clinically Significant Prostate Cancer in Equivocal PI-RADS 3 Lesions.
Hectors SJ; Chen C; Chen J; Wang J; Gordon S; Yu M; Al Hussein Al Awamlh B; Sabuncu MR; Margolis DJA; Hu JC
J Magn Reson Imaging; 2021 Nov; 54(5):1466-1473. PubMed ID: 33970516
[TBL] [Abstract][Full Text] [Related]
3. MRI-Based Radiomics Nomogram for Predicting Prostate Cancer with Gray-Zone Prostate-Specific Antigen Levels to Reduce Unnecessary Biopsies.
Zhang L; Zhang J; Tang M; Lei XY; Li LC
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553012
[TBL] [Abstract][Full Text] [Related]
4. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study.
Jin P; Shen J; Yang L; Zhang J; Shen A; Bao J; Wang X
BMC Med Imaging; 2023 Mar; 23(1):47. PubMed ID: 36991347
[TBL] [Abstract][Full Text] [Related]
5. Utility of Clinical-Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions.
Jin P; Yang L; Qiao X; Hu C; Hu C; Wang X; Bao J
Front Oncol; 2022; 12():840786. PubMed ID: 35280813
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Based on T2-Weighted Imaging and Apparent Diffusion Coefficient Images for Preoperative Evaluation of Lymph Node Metastasis in Rectal Cancer Patients.
Li C; Yin J
Front Oncol; 2021; 11():671354. PubMed ID: 34041033
[TBL] [Abstract][Full Text] [Related]
7. A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients.
Zhang W; Mao N; Wang Y; Xie H; Duan S; Zhang X; Wang B
Eur J Radiol; 2020 Jul; 128():109020. PubMed ID: 32371181
[TBL] [Abstract][Full Text] [Related]
8. Development and external validation of a novel nomogram to predict prostate cancer in biopsy-naïve patients with PSA <10 ng/ml and PI-RADS v2.1 = 3 lesions.
Hu C; Sun J; Xu Z; Zhang Z; Zhou Q; Xu J; Chen H; Wang C; Ouyang J
Cancer Med; 2023 Feb; 12(3):2560-2571. PubMed ID: 35920264
[TBL] [Abstract][Full Text] [Related]
9. Modified Predictive Model and Nomogram by Incorporating Prebiopsy Biparametric Magnetic Resonance Imaging With Clinical Indicators for Prostate Biopsy Decision Making.
Pan JF; Su R; Cao JZ; Zhao ZY; Ren DW; Ye SZ; Huang RD; Tao ZL; Yu CL; Jiang JH; Ma Q
Front Oncol; 2021; 11():740868. PubMed ID: 34589437
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced Spectral Mammography-Based Radiomics Nomogram for Identifying Benign and Malignant Breast Lesions of Sub-1 cm.
Lin F; Wang Z; Zhang K; Yang P; Ma H; Shi Y; Liu M; Wang Q; Cui J; Mao N; Xie H
Front Oncol; 2020; 10():573630. PubMed ID: 33194677
[TBL] [Abstract][Full Text] [Related]
11. [The value of machine learning models based on biparametric MRI for diagnosis of prostate cancer and clinically significant prostate cancer].
Qiao XM; Hu CH; Hu S; Hu CH; Wang XM; Shen JK; Ji LB; Song Y; Bao J
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1446-1454. PubMed ID: 37198106
[No Abstract] [Full Text] [Related]
12. Magnetic resonance imaging radiomics-based prediction of clinically significant prostate cancer in equivocal PI-RADS 3 lesions in the transitional zone.
Zhao YY; Xiong ML; Liu YF; Duan LJ; Chen JL; Xing Z; Lin YS; Chen TH
Front Oncol; 2023; 13():1247682. PubMed ID: 38074651
[TBL] [Abstract][Full Text] [Related]
13. Prediction of clinically significant prostate cancer with a multimodal MRI-based radiomics nomogram.
Jing G; Xing P; Li Z; Ma X; Lu H; Shao C; Lu Y; Lu J; Shen F
Front Oncol; 2022; 12():918830. PubMed ID: 35912175
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative prediction of HER-2 expression status in breast cancer based on MRI radiomics model].
Zhang Y; Huang H; Yin L; Wang ZX; Lu SY; Wang XX; Xiang LL; Zhang Q; Zhang JL; Shan XH
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):428-437. PubMed ID: 38742356
[No Abstract] [Full Text] [Related]
15. Radiomics Nomogram for Identifying Sub-1 cm Benign and Malignant Thyroid Lesions.
Wu X; Li J; Mou Y; Yao Y; Cui J; Mao N; Song X
Front Oncol; 2021; 11():580886. PubMed ID: 34164333
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric MRI for Prostate Cancer Characterization: Combined Use of Radiomics Model with PI-RADS and Clinical Parameters.
Woźnicki P; Westhoff N; Huber T; Riffel P; Froelich MF; Gresser E; von Hardenberg J; Mühlberg A; Michel MS; Schoenberg SO; Nörenberg D
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630787
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the diagnostic capacity of PSAMR combined with PI-RADS scoring for clinically significant prostate cancer and establishment and validation of the Nomogram prediction model.
Li D; Zhang L; Xu Y; Wu X; Hua S; Jiang Y; Huang Q; Gao Y
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11309-11317. PubMed ID: 37365430
[TBL] [Abstract][Full Text] [Related]
18. Combining Multiparametric MRI Radiomics Signature With the Vesical Imaging-Reporting and Data System (VI-RADS) Score to Preoperatively Differentiate Muscle Invasion of Bladder Cancer.
Zheng Z; Xu F; Gu Z; Yan Y; Xu T; Liu S; Yao X
Front Oncol; 2021; 11():619893. PubMed ID: 34055600
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J
J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586
[TBL] [Abstract][Full Text] [Related]
20. A nomogram based on PI-RADS v2.1 and clinical indicators for predicting clinically significant prostate cancer in the transition zone.
Wei C; Pan P; Chen T; Zhang Y; Dai G; Tu J; Jiang Z; Zhao W; Shen J
Transl Androl Urol; 2021 Jun; 10(6):2435-2446. PubMed ID: 34295730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]